Global Neurology Academy

PBA Treatment May Reverse Signs of Alzheimer’s Disease

ReachMD Healthcare Image
RestartResume

Tune in to hear how a fatty acid molecule is being studied in Alzheimer’s disease for its potential impacts on memory retention.

  • Overview

    According to new research featured in Aging Biology, a treatment involving 4-phenylubrate (PBA) may delay or reverse signs of Alzheimer’s disease. To learn more, Dr. Andrew Wilner dives into the results and potential implications of this mouse-model study with Dr. Jini Naidoo, Research Associate Professor of Sleep Medicine at the Perelman School of Medicine at the University of Pennsylvania.

Facebook Comments

Register

We’re glad to see you’re enjoying Global Neurology Academy…
but how about a more personalized experience?

Register for free